~~<i id='5C238EE130'><strike id='5C238EE130'><tt id='5C238EE130'><pre id='5C238EE130'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：hotspot 2025-09-28 19:25:31 - browse：52

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Weight loss drugs should be covered by insurers, AMA says

entertainment

explore

Wikipedia

hotspot

Wikipedia

knowledge

StefaniReynolds/GettyImagesYou’rereadingthewebeditionofD.C.Diagnosis,STAT’stwice-weeklynewsletterabo

WSS

Weight loss drugs should be covered by insurers, AMA says

A letter from the executive editor: STAT UnitedHealth investigation

Leqembi, other new Alzheimer’s drugs require better biomarkers

Type 2 diabetes prevention programs work at large scale: study

Why 40% Americans with Parkinson’s don’t see a neurologist

Carbon Health diabetes program, a test of data

focus

hotspot

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What is STAT's opinion section for?

Sports medicine is finally prioritizing gender equality

Palantir health business leans on meeting customers’ needs

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Alkermes shareholders re

It's time to get medical device identifiers over the finish line

ChatGPT in medicine: STAT answers readers' burning questions

Iowa House, Senate pass 6

explore

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

It's time to get medical device identifiers over the finish line

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Cancer diagnosis changes perspective doctor, former hospital CEO

Wikipedia

hotspot

Wikipedia

knowledge